Xerox and Fuji Xerox Positioned in the Leaders Quadrant of 2012 Managed Print Services Report

November 8, 2012

TOKYO, November 08, 2012— Xerox Corporation and Fuji Xerox Co., Ltd. have been placed by Gartner, Inc. in the Leaders Quadrant of the 2012 Magic Quadrant for Managed Print Services (MPS) WorldwideNote1.

Xerox and Fuji Xerox have been providing its MPS called XOS that optimizes the office print environment by undertaking the management of print devices and relevant matters. As a market leader of MPS, they are offering Enterprise Print Services, which augments the existing MPS covering the entire enterprise print environments – from supporting mobile workers and print governance tools to realize print optimization, to securing confidential data by printing through IC card authentication, and simplifying complex business processes with new ways to work with both paper and digital information.

Fuji Xerox acquired Upstream Print Solutions Pty Ltd., an Australia's largest independent MPS provider in 2010, and has been providing printer-centric MPS for the small- and medium-sized businesses (SMB) market. To further accelerate its provision of services in the Asia-Pacific region, the company also acquired the Business Process Outsourcing division of Australia's largest business service provider, Salmat Limited.

Developed by Gartner to evaluate technology providers based on completeness of vision and ability to execute, the Magic Quadrant is a proprietary research tool, which provides insight into a market's direction, maturity and participants.

Gartner, Inc., Magic Quadrant for Managed Print Services, Worldwide, Ken Weilerstein, Cecile Drew, October 24, 2012.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.